Glenmark Pharmaceuticals will launch a 400 mg version of oral antiviral drug FabiFlu, which will be used to treat mild to moderate Covid-19 patients...
After encouraging results in an attempt to revive brain dead subjects, Revita Life Sciences -- a biotechnology company focused on translational regenerative therapeutic applications,...
The Delhi High Court on Friday directed the AAP government to take action against online health service aggregators that are allegedly operating illegally regarding...
CSIR-IICT director S. Chandrasekhar tells The Daily Guardian that Ciplenza, indigenous version of Favipiravir, will be much cheaper and thus not out of the reach for common people.
Even after 10 months, medical students of World College of Medical Sciences in Jhajjar, Haryana, are continuing their protests and are demanding to get...
Hepatitis is a condition that causes inflammation of the liver. Today, Hepatitis viruses are the most common cause of hepatitis but other infections, toxic...
